OKYO Pharma Limited (NASDAQ:OKYO – Get Free Report) saw a large growth in short interest in the month of July. As of July 15th, there was short interest totalling 48,300 shares, a growth of 21.7% from the June 30th total of 39,700 shares. Based on an average daily volume of 22,000 shares, the short-interest ratio is presently 2.2 days. Currently, 0.2% of the shares of the company are short sold.
OKYO Pharma Price Performance
OKYO traded up $0.01 during midday trading on Friday, hitting $1.36. 28,651 shares of the company were exchanged, compared to its average volume of 32,025. The company’s 50 day simple moving average is $1.37 and its 200 day simple moving average is $1.44. OKYO Pharma has a 1-year low of $1.09 and a 1-year high of $3.07.
Analyst Upgrades and Downgrades
Separately, HC Wainwright reaffirmed a “buy” rating and set a $7.00 price target on shares of OKYO Pharma in a research report on Thursday, July 11th.
OKYO Pharma Company Profile
OKYO Pharma Limited, a clinical-stage biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead preclinical product candidate is OK-101, which is in Phase II clinical trials for the treatment of dry eye disease.
Further Reading
- Five stocks we like better than OKYO Pharma
- Breakout Stocks: What They Are and How to Identify Them
- Is Crypto Cool Again? What Stocks You Should Be Watching
- Investing in Travel Stocks Benefits
- Why Call Options Volume for These 2 Stocks Spiked Together
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- MarketBeat Week in Review – 7/22 – 7/26
Receive News & Ratings for OKYO Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OKYO Pharma and related companies with MarketBeat.com's FREE daily email newsletter.